483
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Synergistic Antioxidant Activity of Size Controllable chitosan-templated Prussian Blue Nanoparticle

, , , , , & show all
Pages 2567-2578 | Received 31 May 2019, Accepted 26 Jun 2019, Published online: 19 Jul 2019
 

Abstract

Aim: Prussian blue nanoparticles (PB NPs) have been reported as excellent antioxidant agents owing to their ability to scavenge reactive oxygen species. However, their poor stability in vivo limits their use in biomedical applications. Materials & methods: In this study, we developed chitosan-templated PB NPs using water-soluble chitosan samples with molecular weights ranging from 3 to 100 kDa, which stabilized the PB NPs and improved their antioxidant activity. Results & conclusion: The chitosan-templated PB NPs coordinated with the optimal chitosan molecular weight had uniform sphere-like particles, improved stability and effective scavenging activity of in vitro reactive oxygen species generation in murine fibroblast cells stimulated by oxidative stress agents without any cytotoxicity, implying that they could be promising antioxidant agents.

Graphical abstract

The size controllable chitosan-templated Prussian blue nanoparticles with different molecular weights of chitosan from 3 to 100 kDa were developed for synergistic antioxidant activity.

Supplementary data

To view the supplementary data that accompany this paper please visit the journal website at:www.tandfonline.com/doi/full/10.2217/epi-2016-0184

Financial & competing interests disclosure

This research was supported by the National Research Foundation of Korea (NRF) grant number NRF-2018R1D1A1B07043620 (WI Choi) and NRF-2017R1C1B5018050 (J-M Lim) funded by the Korea government (MSIT) and the Soonchunhyang University Research Fund (J-M Lim). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.